Sie befinden sich hier

Inhalt

Mannheim Center for Translational Neuroscience

The Mannheim Center for Translational Neuroscience (MCTN) at Heidelberg University provides a platform for basic research-oriented, translational and clinical neuroscientists from the Medical Faculty Mannheim to work closely with the Central Institute for Mental Health, the life science research institutions of the University Heidelberg and with the non-university research institutions in the Rhine-Neckar metropolitan area.

Upcoming Talks and Events 

13.05.2024 – 14.05.2024, 9 am – 4 pm

Final Symposium Research Training Group “The Impact of Adverse Childhood Experiences on Psychosocial and Somatic Conditions Across the Lifespan” (GRK 2350) 

Location: Cubex One, Franz-Volhard-Straße 5, 68163 Mannheim

More Information and Registration

News

Michael Platten has been awarded the 2024 Paul Martini Prize for the development of therapeutic vaccines against malignant brain tumors. The prize is awarded annually by the Paul Martini Foundation, Berlin, for outstanding achievements in clinical-therapeutic drug research. It is endowed with €50,000. read more …

This year, the European Research Council (ERC) awarded the prestigious grants to neuropsychologist and clinical psychologist Herta Flor (CIMH), who aims to improve the prevention of chronic pain and to neurologist Michael Platten (DKFZ and University Medical Center Mannheim), who will use the ERC funding to develop and test personalized cellular immunotherapies against malignant brain tumors. read more …

A new technology for all-optical monitoring and manipulation of neuronal circuits, based on 3D holography, will be established at the MCTN. Under the leadership of Simon Wiegert an application for an upright two-photon microscope for intravital fluorescence microscopy and photostimulation was approved by the German Research Foundation. read more …

Making a personalized T cell therapy for cancer patients currently takes at least six months. Scientists at the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim have shown that the laborious first step of identifying tumor-reactive T cell receptors for patients can be replaced with a machine learning classifier that halves this time. read more …

Researchers from the BioMed X Institute and the University Medical Centre Mannheim have published the results of their collaboration on a novel neoepitope vaccine against diffuse midline glioma in the journal Science Advances. read more …

Simon Wiegert receives ERC funding to develop a hyperspectral fiber photometry system that can be used flexibly for a wide range of optical measurements of brain function. read more …

At our Imaging in Neuroscience Symposium on December 7th at the University Hospital Mannheim, scientists presented their latest research and discussed new developments in the field of live imaging and the study of brain physiology and pathophysiology at different spatial and temporal scales. We look back on a very interesting and inspiring day with insightful presentations, interesting questions and important discussions with more than 90 attendees on site. read more ...

Neurologist and MCTN director Michael Platten and psychiatrist and CEO Andreas Meyer-Lindenberg from the Central Institute of Mental Health are listed among the world's most cited scientists in the category “cross field”.  read more …


Kontextspalte

ALUMNI

Prof. Dr. Rolf-Detlef Treede
(former MCTN Co-Director)

Prof. Dr. Martin Bohus